Location History:
- Shandong, CN (2012)
- Plymouth, MN (US) (2010 - 2014)
Company Filing History:
Years Active: 2010-2014
Title: Innovations by Wei Qin in Blood Coagulation Testing
Introduction
Wei Qin is an accomplished inventor based in Plymouth, MN (US). He has made significant contributions to the field of medical technology, particularly in the area of blood coagulation testing. With a total of 3 patents to his name, his work has the potential to enhance patient care and improve diagnostic accuracy.
Latest Patents
Wei Qin's latest patents include a "Point of Care Heparin Determination System" and a "Membrane System for Blood Coagulation Testing." The point of care heparin determination system describes methods and devices for determining heparin concentration in blood. This system includes cartridges with protamine ion-sensitive electrodes (ISEs) and reference electrodes, which automatically determine heparin concentration. The system can add blood to a protamine bolus sufficient to bind all heparin, leaving excess protamine. The concentration of excess protamine can be determined by measuring the initial slope of the electrode potential rate of change and comparing it to known protamine concentration slope values. Additionally, some cartridges utilize an oscillating pressure source to move the blood-protamine mixture across the protamine ISE. The membrane system for blood coagulation testing involves articles designed for testing the coagulation process in whole blood.
Career Highlights
Wei Qin is currently employed at Medtronic, Inc., a leading company in medical technology. His innovative work has contributed to advancements in point-of-care testing, which is crucial for timely medical interventions. His patents reflect a deep understanding of both the technical and clinical aspects of blood coagulation.
Collaborations
Wei Qin has collaborated with notable colleagues, including Daniel Cheek and Christopher M. Hobot. These collaborations have likely enriched his research and development efforts, leading to impactful innovations in the medical field.
Conclusion
Wei Qin's contributions to blood coagulation testing through his patents demonstrate his commitment to improving healthcare technology. His work at Medtronic, Inc. continues to influence the landscape of medical diagnostics.